ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001155.1|GE2270_1 # 3 # 104 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.598	BGC0001155.1|GE2270_1 	3	104	+	Loose	1050	20.4014	YojI	30.0	3003952	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTAATGTCCACCTGGTGGGCGTATAGTTATTGGGCTGGGGGCATAATGACTATCCGTATCCGGTCGTGCAACGCGCTGCGGTCGCGGCGGGAAAGCGCGTGA	VMSTWWAYSYWAGGIMTIRIRSCNALRSRRESA	MELLVLVWRQYRWPFISVMALSLASAALGIGLIAFINQRLIETADTSLLVLPEFLGLLLLLMAVTLGSQLALTTLGHHFVYRLRSEFIKRILDTHVERIEQLGSASLLAGLTSDVRNITIAFVRLPELVQGIILTIGSAAYLWMLSGKMLLVTAIWMAITIWGGFVLVARVYKHMATLRETEDKLYTDFQTVLEGRKELTLNRERAEYVFNNLYIPDAQEYRHHIIRADTFHLSAVNWSNIMMLGAIGLVFWMANSLGWADTNVAATYSLTLLFLRTPLLSAVGALPTLLTAQVAFNKLNKFALAPFKAEFPRPQAFPNWQTLELRNVTFAYQDNAFSVGPINLTIKRGELLFLIGGNGSGKSTLAMLLTGLYQPQSGEILLDGKPVSGEQPEDYRKLFSAVFTDVWLFDQLLGPEGKPANPQLVEKWLAQLKMAHKLELSNGRIVNLKLSKGQKKRVALLLALAEERDIILLDEWAADQDPHFRREFYQVLLPLMQEMGKTIFAISHDDHYFIHADRLLEMRNGQLSELTGEERDAASRDAVARTA	6.03	gnl|BL_ORD_ID|4707|hsp_num:0	2424			453	513	microcin J25
BGC0001155.1|GE2270_2 # 101 # 814 # 1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.641	BGC0001155.1|GE2270_2 	101	814	+	Loose	400	49.2914	MexL	41.51	3003710	protein homolog model	n/a	n/a	macrolide antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGACGAGCTCGCGCAGTAATGCCGAACGAGTGGTCCGAATCATCGACGCATCTGCGGAGCTTTTACTCCAGAGGGGATATCGACGGGTGACCGTCGAGGAGGTCGCCAGCCATGCCGGTGTCTCCAAGAGCAGCGTCTACCTGCACTGGAACACGAAGGACGACATCTTCTACGACGCTCTCGACCGCGAGTGCGCCGCGCTCGTGTGCGAGGCCGTCGACCGCGTCAGACGCAACCCGGCCGAAATCCTGGCTCACCGGATGGCGGCCAATCTGCTCCGGATCATCCTGGACAGGCCGCTGCTGCGGGCGCTGCTGATGGGTGACCAGGCGATTCTGGGATCGCTCCGCCATGCGAAGTCGTCCGCTCTCCGATCCCGGACGGCGGCAATTGACGAGCTGATTCACCGATATCTCTCAGCGCTGCAGAAAAACCAACTCATCTGTCCCGACATCGATCTGCGCATCACCCGGAAAGCGGTGTGGGAAATGCTGCGCGGCATGATTTTCTCGGCGGGGACGGAGCCGTTGGGCAAGCCGCGCTCCGCCGAGCTGGCGCAGGTCATGACGGTTACCGTGCGGCGGGCGTTCGAGCCCAGGGGCGTACCGGGGATCGACCGGATCACCGCCGCCGCGGCCGAGGTCTTCGAGGCGTTCGACGAACTCATTCCGACCGCGGAGAACCTGGACTTCGAGCGCCCGATGGTGCTATGA	MTSSRSNAERVVRIIDASAELLLQRGYRRVTVEEVASHAGVSKSSVYLHWNTKDDIFYDALDRECAALVCEAVDRVRRNPAEILAHRMAANLLRIILDRPLLRALLMGDQAILGSLRHAKSSALRSRTAAIDELIHRYLSALQKNQLICPDIDLRITRKAVWEMLRGMIFSAGTEPLGKPRSAELAQVMTVTVRRAFEPRGVPGIDRITAAAAEVFEAFDELIPTAENLDFERPMVL	MSESTSSVGPGRPKDPAKREAILEAAKRLFLCNGYDGSSMEAIASEAGVSKLTVYSHFTDKETLFSEAVKAKCAEQLPALYFQLAEGAPLEKVLLNIARGFHRLINSHEAIALTRLMAAQAGQNPKLSELFFEAGPKQVIDEMERLLEQARRSGKLAFPDARHAAEHFFMLVKGCANYRLLIGCAEPLDEAEGERHVEEVVALFLRAFAAGG	111.79	gnl|BL_ORD_ID|4690|hsp_num:0	2219			63	222	erythromycin; tetracycline; triclosan
BGC0001155.1|GE2270_3 # 868 # 2691 # 1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.730	BGC0001155.1|GE2270_3 	868	2691	+	Loose	800	27.7202	ParS	28.3	3005067	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics	antibiotic efflux; reduced permeability to antibiotic	resistance-nodulation-cell division (RND) antibiotic efflux pump; Outer Membrane Porin (Opr)	GTGCTCGCCGACCGGCTCTCGGCGGTGCCGGCCGGGCTCGATCCGGATCTGGTGCTGGCCGTATCGGACGCGCCCGATCCCGCGGTGCTCGCCGCGGCGAGAGCGACGGGCCGCCCGGTGCTGCCGGTGATCGCCGAGATGGGGCACGTCCGCATCGGACCGCTGGAACGGCCGGGCGAGCCGGGGTGCTCCGACTGCCTGAGCATCCGCAGACATCGTGCCGCCACCCGGTCGGCCGAACGCGAGGCGGTGTGGCTGAGACACGGCGAGAGCATGGCCGGTGCGATGTCGCCGCTGCTCGTGCCGGCGGCACTGGACCTGGTGGCCGCGCTCGTCGCCGGAGCGGCGGCGGGGCGCGGCGGCATTCTGCTGGTCGACCTCGCCGACCTCGCCGTGACGCCGCACTCGTTCCTGCCCGATCCGCTCTGCGGCCGGTGCGGGGAACTGCCGGACGACAGCCCGGAGCGTGCGCGCGTCACGTTGGTGCCGCGGCCGAAGCCCGCTCTGGACCAGTACCGGGTGTGGGACGCCGAACACGAACTGGACCGCCTGATCCGGACCTACGTCGACGACCACACCGGTCTCGTGAACTCGCTCACCCCGGCGGCGCTCGGTTCGCTCGCCGTCGCGGGAGCGGCGATCCGGCTACGCGGGACGACGGTGTTCGAACCGGGCTTCGGCCGGTCCCGCAGCTACCGCCGCAGCTCGGCCATCGCGTTGCTCGAAGCGCTGGAGCGGTACGGCGCCATCGGCCCCGGCGGCAGGCGCGGAACCGTACGCGCGAGCTACGCGTCCCTGGGCGACCGGGCGGTGGATCCACGGTCGCTGGGCCTGCACCCGCCCACGCACTACGCGCTGCCGGACTTCCCGTACCGGCCGTTCACGGTCGACGCGGTGTGCCGTTGGGTGTGGGGGCACTCGTTCGCGGCCGGTGGTCCCGTGCTGGTGCCGGAGCGCAACGTCTACTACGGGCGCTCCGACGACCAGCCGTTCTGCTACGAGCTCGCCAACGGCTGCGCCCTGGGATCGTGCCTGGAGGAGGCGATCTTCCACGGCATCCTGGAGGTGCTGGAACGCGACGCGTTCCTGCTGACCTGGTACACCCGTGCGCGGGCCCCGCGCATCGATCTCGGCACGGCCCGCGATCCGGGGATCCCGCTGGTCGCCGCGGCGATCACCGCCGAGACCGGTTACCTCGTCGAGTGCTACGACATCACGCCCGACCACGGAGTGCCGTGCGTGTGGGCGCTGGCCCGTACGCTGTCCGGTGAGCCCGCCACGATCAGCGCCGCCGCCGCCGGGACCAGCCTGGAACACGCCGCCGCGGGGGCGCTCGCCGAACTCGGCCCGATGGTGCCGACCGTGCGCGAGCACTTCCCCCCGAACGCCGACCGAGCACGGACGCTGGCCGCCGACGGCAGCCGGGTACGGTCGATGATCGACCATTACCTGGTGTACGGAGTGCGGTCGGCGGCGGAGCGGTTGTCGTTCCTCACCGAGGGGACGACGCGGGTGCCGTTCCCACCGCCTCCCGAAGGGTTCCGGCACCAGGATCTGACCCTCGACCTGGAGTTTCTGATCGACCGGCTCGCGGACGTCGGGCTCGACGTGATCGTGGTCGATCTGACGACACCGGAGCATCGCGCGGGCGGCCTGCGCTGCGTGAAGGTGCTCGTGCCCGGTGCGGTCCCGATGACGTTCGGGGAGCAGAACCGCCGCACCTGGGGGCTGCCGCGACTGCTGGACCCGGCCGCGGTGCGCGGACGGGGGATGCCGGTGCGTGTCCACGCCGACCTGAACCCCGACCCCCACCCGTTCCCGTGA	MLADRLSAVPAGLDPDLVLAVSDAPDPAVLAAARATGRPVLPVIAEMGHVRIGPLERPGEPGCSDCLSIRRHRAATRSAEREAVWLRHGESMAGAMSPLLVPAALDLVAALVAGAAAGRGGILLVDLADLAVTPHSFLPDPLCGRCGELPDDSPERARVTLVPRPKPALDQYRVWDAEHELDRLIRTYVDDHTGLVNSLTPAALGSLAVAGAAIRLRGTTVFEPGFGRSRSYRRSSAIALLEALERYGAIGPGGRRGTVRASYASLGDRAVDPRSLGLHPPTHYALPDFPYRPFTVDAVCRWVWGHSFAAGGPVLVPERNVYYGRSDDQPFCYELANGCALGSCLEEAIFHGILEVLERDAFLLTWYTRARAPRIDLGTARDPGIPLVAAAITAETGYLVECYDITPDHGVPCVWALARTLSGEPATISAAAAGTSLEHAAAGALAELGPMVPTVREHFPPNADRARTLAADGSRVRSMIDHYLVYGVRSAAERLSFLTEGTTRVPFPPPPEGFRHQDLTLDLEFLIDRLADVGLDVIVVDLTTPEHRAGGLRCVKVLVPGAVPMTFGEQNRRTWGLPRLLDPAAVRGRGMPVRVHADLNPDPHPFP	MLRLFLRLYLLLALGFAAAIFVVDHVIDAFYDSIVENYHRDAVRGQAYSLVEKLAPLDQAGRQRQLEDWRPHYGLELSLTDARQAKLTQEEQALLDKNLLVVREDFTEFISRIDAGPQLLDIKLPPEPSLTPLFTVLAYILLGVLVGIALLVWVRPHWRDLETLRLAAQRFGDGDLSSRTRIFRRSDIRTLAQHFNQMADRIESLISNQRELTNAVSHELRTPISRLSFELEQLNKQVDAEVRHDLIEDMRADLGELEEMVSELLTYARLEHGNVGSHREIVDAASWLDSVVADVALEAEAAGVTCEISACQVEQIRIEPRFMARAVINLLRNAIRHAHSRVEIALLDQGDSCQIRVNDDGPGIPADARQKIFEPFSRLDDSRDRSTGGFGLGLAIVHRVAQWHGGYAEALETPQGGASFRLTWERPR	141.82	gnl|BL_ORD_ID|2790|hsp_num:0	3805			561	708	erythromycin; amikacin; gentamicin C; ciprofloxacin; acriflavine; tetracycline; tobramycin; meropenem; imipenem; chloramphenicol; norfloxacin; ofloxacin; gentamicin
BGC0001155.1|GE2270_4 # 2688 # 5066 # 1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.736	BGC0001155.1|GE2270_4 	2688	5066	+	Loose	890	28.4906	smeF	32.56	3003057	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; tetracycline antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAACCGCGCGGTCGCCAGGGTCGGCGGACTGCCGCTGTCCGCTCTGGACGCTCTGGCCTGCCCTGACGCCACGGCTCTGGCCGCCTGTGTCGTCTCGCTCACCGACGAGTTGTCCCGGCGGGCCGCGGTGCTGTCCGACCTCCTGTACGAGGTGATCGGCGCCGCGGAGGAGCACAAGCCCGTCCTGGTGGCGATCCGGCGGGACCTGCACGGGCTGCGTCGGCCCAAGCGGATCGAGGTGCTGCCCGCGGCGCTGCTGGATCGGGTCCATGAGTGGATCTCCCTCTGGGAACAGCGCGCGCGGGCCCGCGCCGCGTTGCCCGAGGTGCTCGCGGGTGAGGCCCGGACGGCCTGGGCGTCGCTGCGGGAGCTGGCCGCCGCTCCGGCGGTACGGCACGGGCTCGCGCACGCCAGCCCGGACCTGTCCGCGGAACTGGAGAAGTGGCTCGCCGACCCGGGGCGACGGCCCCGGGCGGGGACACTGGCGAGCCTGCTGCGCTACGTCACCCGGGTGGCGGCCAAGACGAGTCCTTTCAGCACGTTCACGAGCGTTCACCGCGTGCACTGGGAGATGGAGGGGACGGGCTGGGAGATACCCGACTCACCGCCGACCGTGGTGGTCGAGGCCGATGTGGGACTCCGGCTGCTGGTGGAGTTCATGGTGCCACGATGGCCAGGACCGGCCGCGGCGCGTACGGTCCGGCTGTCGCCGACCGCGTACATGTCCGGGCGGAAGCTGCTCTTCCTCGGCCCGGACGGGCGGACGCGCGCACTCGAACGGACGGCGGCGCTGGATGCCCTCGTCGAGTTGCTGCGTGCCGAGCACGGGGCCCGGTGGGACGTGGTGGCCGGCAAGCTCGCCGCAGAAGACCGCGAGCAGGGGGAGGAGACCCTGGCCCGGCTGGTGCGCGGCGGGCTGGTGGAGGCGGTGGTGCCGGTGCCCGGCCAGGCGGCGAGGCCGTTCGCGGCCCTCGCGGACTGGGCCCGGGCCGCCGAGGTCGCCCATCCGCTGAACCGCATCCAGCAGGCACTGGACCTCACCGGACCCCTCGGCACCGGTGACCCGGCGACATCGGCCTGCACCGAGGCGGCGCGTCGCGTCACCGCCGAACTCCCCGCGCTCAGCCTTCCCGCCATGCCGCTCCCCGAGCTGCGCCGCCGCGTTCTGCGCGAGTCGACCGTCGGCGCGCCCGTCACCTGCGCGCTCCCGGAGTGGCGACCGGCCCTGGCCGACCTGGAACGGGTCCGCCGCTGGCTGGCGGTCCACGATCCGATGTTGCCGCTCCGCCTTTCCCTGGCGGACCACGTCCGCGACTGGTTCGGCCCGGACTCCAGCCCGCCGCTGCTGGAGGTGTACCTCCGGGTCGAGGCGGCTCAGCCGGGGTCGCCGCTCCACCCCGACTTCCTGGAACGCCCCGACCCCCTGGCGGATGTCGCCGACCCGCGCCTGCGCGGACTGCGCGACCTGCGCGTCCGGACGATCGAGGCGCTTCACGGAGGGCGGGCCGAGGAGATGCTCGGCGAACTGCCGGGGTGGATCGGCGACCCGGGACCGGTCACCTGCTACGTCCAGCCCTTCCATGAGGAGGGCGAGCTCAGGCTGGTCCTCAACACCGCGCACGGCGGCCACGGCCGGGGCATCACCCGCTGGAGCAGACTTCTGGGCGGCAGTCCGGTGCCGGTCTCCCCCGGCTACCTGGCCGCCGAGCTGCCGGGGGTCTTCGGGCACAGCTTGAACCTGCGCGCTCCCGGCACGGAATGGGAACTCGACTACCCGGGCGCGGTAGGCCAGGCACCGCCGGATCGCCGCATTCCGCTCACCGAGTTGCAGGTCCGGCACGACCAGGCCAGGGGTCTCGTCACCCTGTGGTGGCCGCGTGCCGGCCGGCGGGTCGTCCCGGTACACGCGGGCATGATGTCGGAGACGCTCCTGCCGCCGCTGGCGCGGCTGCTCGTCGAGGCGTTCGGTACCACCTACCTGACCCACCCCACCCTCCCGGCGATCCCGCGGGCGAGCGGCCCTCGGATCGATCTCGGCCGTGTCACCCTCGCCAGAGCCCAGTGGACGGTCGGCCAGGACGCCGTTCCCCGGCGGGAAGACGACGACGCCGATCACTTCGTCGCCGTCCAGCGGTGGCTGCGCCGCACCGGGATTCCGCGCCGTTGCTTCGTGCGCGTCCGGGAACGCCAGGTGAGCAGGGACCGGATCGCGTTCGACAAACGGCACAAGCCGGTGTTCATCGACTTCGGCAGCTGGCCGTCGGTGCTGGAGTTCGACCGGATGGTCGAGCGGACGACCGGCGAGCTGGAAGTGGCGGAGGCGCTGCCCGACGGCGATCGGGCCGTGGAGTTCGCGATCGAGGTGGGGGAACCGTGA	MNRAVARVGGLPLSALDALACPDATALAACVVSLTDELSRRAAVLSDLLYEVIGAAEEHKPVLVAIRRDLHGLRRPKRIEVLPAALLDRVHEWISLWEQRARARAALPEVLAGEARTAWASLRELAAAPAVRHGLAHASPDLSAELEKWLADPGRRPRAGTLASLLRYVTRVAAKTSPFSTFTSVHRVHWEMEGTGWEIPDSPPTVVVEADVGLRLLVEFMVPRWPGPAAARTVRLSPTAYMSGRKLLFLGPDGRTRALERTAALDALVELLRAEHGARWDVVAGKLAAEDREQGEETLARLVRGGLVEAVVPVPGQAARPFAALADWARAAEVAHPLNRIQQALDLTGPLGTGDPATSACTEAARRVTAELPALSLPAMPLPELRRRVLRESTVGAPVTCALPEWRPALADLERVRRWLAVHDPMLPLRLSLADHVRDWFGPDSSPPLLEVYLRVEAAQPGSPLHPDFLERPDPLADVADPRLRGLRDLRVRTIEALHGGRAEEMLGELPGWIGDPGPVTCYVQPFHEEGELRLVLNTAHGGHGRGITRWSRLLGGSPVPVSPGYLAAELPGVFGHSLNLRAPGTEWELDYPGAVGQAPPDRRIPLTELQVRHDQARGLVTLWWPRAGRRVVPVHAGMMSETLLPPLARLLVEAFGTTYLTHPTLPAIPRASGPRIDLGRVTLARAQWTVGQDAVPRREDDDADHFVAVQRWLRRTGIPRRCFVRVRERQVSRDRIAFDKRHKPVFIDFGSWPSVLEFDRMVERTTGELEVAEALPDGDRAVEFAIEVGEP	MEVIPMKSASLFLSIAATLALAGCSTLAPKNTAVAPAIPAQWPAEAAQGEVADVAAVGWRDFFTDARLQQVIEQSLQNNRDLRVAVLNVERARGQYRVQRADRVPGVAVTGQMDRRGTDAGVTEQFSAGVGVAEFELDLFGRVRNLSEAALQQYFAVAANRRNAQLSLVAETATAWLTYGADAQRLKIADATLKTYEDSLRLAEARHERGGSSALELTQTRTLVETARTDAARLRGQLAQDRNALALLAGGQLDPALLPDSIEPQLLALAPPPAGLPSDVLLQRPDIMAAEHQLLAANANIGAARAAFFPSISLTGSIGSGSSELSNLFDSGTRVWSFLPKITLPIFQGGKLRANLAIANADRDIALAQYEKSIQVGFRETADALALNVSLDEQVSSQQRLVEAAEQANRLSQARYDAGLDSFVTLLDARRTAYNAQQTQLQAQLAQQANRITLYKVLGGGWHERG	169.96	gnl|BL_ORD_ID|577|hsp_num:0	634			930	1059	tetracycline; chloramphenicol
BGC0001155.1|GE2270_5 # 5063 # 6097 # 1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=GGGGG;rbs_spacer=4bp;gc_cont=0.742	BGC0001155.1|GE2270_5 	5063	6097	+	Loose	550	27.335	IMI-13	32.84	3006177	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	IMI beta-lactamase	GTGACGCAGTATCCACTGAGCCGTCCGGAGCCGCTCGGGGTCCACCCCGACTACCGGCGGCTCCGTGAGACATGCCCGGTGGCGCGGGTCGGCTCGCCCTACGGCCCGGCCTGGCTGGTCACCCGCTACGCGGACGTGGCGGCGGTGCTGACCGACGCGCGGTTCAGCCGTGCGGCGGCGCCGGAGGACGACGGTGGCATCCTGCTCAACACGGACCCGCCGGAGCACGACAGGCTGCGCAAGCTCATCGTGGCGCACACCGGAACGGCGCGGGTCGAGCGGCTCCGGCCGAGGGCCGAGGAGATCGCGGTCGCGCTGGCACGGCGGATCCCGGGTGAGGGCGAGTTCATCAGCGCGTTCGCCGAGCCGTTCTCGCATCGGGTGCTCAGCCTGTTCGTCGGGCACCTGGTCGGCCTGCCCGCCCAGGACCTGGGTCCGCTGGCCACCGTCGTGACGCTCGCGCCGGTGCCCGACCGGGAGCGGGGAGCCGCCTTCGCCGAGCTGTGCCGGCGGCTCGGGCGCCAGGTGGACCGGGAAACGCTCGCGGTGGTGCTCAACGTCGTCTTCGGCGGGCACGCGGCGGTGGTGGCCGCGCTGGGCTACTGCCTGCTGGCCGCGCTGGACGCACCGCTGCCGAGGCTGGCGGGCGATCCCGAAGGCATCGCCGAGCTGGTCGAGGAGACGCTCCGCCTCGCGCCACCGGGCGACCGGACTCTGCTGCGCCGTACCACGGAGCCGGTGGAGCTGGGCGGGCGGACACTCCCCGCGGGCGCGTTGGTGATCCCGTCGATAGCGGCGGCGAACCGCGACCCGGACCGGCCCGTCGGCCGGCGCATGCCCCGGCATCTGGCGTTCGGCCGAGGCGCGCACGCGTGCCTCGGGATGGCGCTCGCCAGGATGGAGCTGCAGGCGGCGCTCAAGGCGCTGGCCGAGCACGCCCCCGACGTGCGGCTTCCGGCCGGGACGGGCGCCCTCGTGCGAACACATGAAGAATTGTCGGTGAGCCCTCTTGCGGGAATCCCGATTCAGAGGTAA	MTQYPLSRPEPLGVHPDYRRLRETCPVARVGSPYGPAWLVTRYADVAAVLTDARFSRAAAPEDDGGILLNTDPPEHDRLRKLIVAHTGTARVERLRPRAEEIAVALARRIPGEGEFISAFAEPFSHRVLSLFVGHLVGLPAQDLGPLATVVTLAPVPDRERGAAFAELCRRLGRQVDRETLAVVLNVVFGGHAAVVAALGYCLLAALDAPLPRLAGDPEGIAELVEETLRLAPPGDRTLLRRTTEPVELGGRTLPAGALVIPSIAAANRDPDRPVGRRMPRHLAFGRGAHACLGMALARMELQAALKALAEHAPDVRLPAGTGALVRTHEELSVSPLAGIPIQR	MSLNAKPSRIGILFSSCLVLISFFSQANTKGIDEIKSLETDFNGRIGVYALDTGSGKSFSYRANERFPLCSSFKGFLAAAVLKGSQDNQLNLNQIVNYSTRSLEFHSPITTKYKDNGMSLGDMAAAALQYSDNGATNIILERFIGGPEGMTKFMRSIGDEVFRLDRWELDLNTAIPGDERDTSTPAAIGKSLENLALGNILSEREKETYQTWLKGNTTGATRIRASVPSDWVVGDKTGSCGAYGTANDYAVVWPKNRAPLIISVYTTKNQKEAKHDDKVIAEASRIAIDNLK	117.81	gnl|BL_ORD_ID|3598|hsp_num:0	4667			375	567	
BGC0001155.1|GE2270_6 # 6570 # 6869 # 1 # ID=1_6;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.687	BGC0001155.1|GE2270_6 	6570	6869	+	Loose	1800	24.2534	mdtC	27.63	3000794	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGCAGCCCAATCCGTTCTACACGAGCGGGAAGAGCGCGTCGGCGGGCAGCCGGCTGCGCATTTACCCCGAGTACGCGACCAGCGAGCTGTCGGCGCGGCTGAGCGAGCGTTATCTCTCGACGTTCTACCAGCGCACCCTGCTCAAGCGCGTCGTTCTCGACCCGGCCACCGTCGTCGAGGACGCGGACGCCGGTGAGGGCGTCACCGTGAGCCGGTCGCACTACAAGGGCGTCGAGTTCGACCTGCACACCAGGGCCGAGGGCGCGGACCGCGAGATCATCGCCGCGTTCGTGCGCTGA	MQPNPFYTSGKSASAGSRLRIYPEYATSELSARLSERYLSTFYQRTLLKRVVLDPATVVEDADAGEGVTVSRSHYKGVEFDLHTRAEGADREIIAAFVR	MKFFALFIYRPVATILLSVAITLCGILGFRMLPVAPLPQVDFPVIIVSASLPGASPETMASSVATPLERSLGRIAGVSEMTSSSSLGSTRIILQFDFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGELYDFASTQLAPTISQIDGVGDVDVGGSSLPAVRVGLNPQALFNQGVSLDDVRTAVSNANVRKPQGALEDGTHRWQIQTNDELKTAAEYQPLIIHYNNGGAVRLGDVATVTDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSIRAKLPELQETIPAAIDLQIAQDRSPTIRASLEEVEQTLIISVALVILVVFLFLRSGRATIIPAVSVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENIARHLEAGMKPLQAALQGTREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLLVSLTLTPMMCGWMLKASKPREQKRLRGFGRMLVALQQGYGKSLKWVLNHTRLVGVVLLGTIALNIWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIRDDPAVDNVTGFTGGSRVNSGMMFITLKPRDERSETAQQIIDRLRVKLAKEPGANLFLMAVQDIRVGGRQSNASYQYTLLSDDLAALREWEPKIRKKLATLPELADVNSDQQDNGAEMNLVYDRDTMARLGIDVQAANSLLNNAFGQRQISTIYQPMNQYKVVMEVDPRYTQDISALEKMFVINNEGKAIPLSYFAKWQPANAPLSVNHQGLSAASTISFNLPTGKSLSDASAAIDRAMTQLGVPSTVRGSFAGTAQVFQETMNSQVILIIAAIATVYIVLGILYESYVHPLTILSTLPSAGVGALLALELFNAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRHGNLTPQEAIFQACLLRFRPIMMTTLAALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRKPKQTVTE	9.66	gnl|BL_ORD_ID|1212|hsp_num:0	1315			2139	2364	novobiocin
BGC0001155.1|GE2270_7 # 6914 # 8032 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.710	BGC0001155.1|GE2270_7 	6914	8032	+	Loose	400	28.1054	ErmT	37.21	3000595	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGCTCAGCAGCGCCCTGGAAGTAGACATCGACGAGGCGGCCGTCGCCGCCGACCTCAGAGAACTGGCCGCGGCACTCGACCGCAGCGGCTACGGAGAGATCCTGACGTGCTTCCTGCCGCAGAAAGCGCAGGCCCACATCTGGGCGCAGACCGCGGCGAAGATCGATGGTCCGCTGCGGACCCTGATGGAGCTCTTCCTGCTCGGCCGCGCGGTGCCGCAGGACGACCTCCCGCCCCGGATCGCCGCGGTGATCCCCGGCCTCGTCTCCGCGGGGCTGGTCAAGACGGGGCAGGGCGCCGTGTGGCTGCCCAACCTCATCCTGCTCCGGCCGATGGGCCAGTGGCTGTGGTGCCAGCGCCCGCACCCCTCGCCCACCATGTACTTCGGCGACGACTCGCTCGCGCTGGTGCACCGCATGGTGACCTACCGCGGCGGCCGCGCCCTCGACCTGTGCGCGGGGCCGGGCGTGCAGGCGCTGACGGCGGCGCTGCGCAGCGAGCACGTCACGGCGGTCGAGATCAACCCGGTGGCGGCGGCGCTGTGCCGTACCAACATCGCCATGAACGGACTCTCGGACCGGATGGAGGTCCGCCTCGGCAGCCTCTACGACGTCGTGCGGGGCGAGGTCTTCGACGACATCGTGTCGAACCCGCCGCTGCTGCCGGTCCCCGAGGACGTGCAGTTCGCGTTCGTCGGCGACGGCGGCCGTGACGGCTTCGACATCTCCTGGACCATCCTCGACGGCCTGCCCGAGCATCTGTCCGACCGCGGAGCATGCCGCATCGTCGGCTGCGTGCTGAGCGACGGCTACGTGCCCGTCGTGATGGAAGGCCTCGGCGAATGGGCGGCGAAGCACGACTTCGACGTGCTGCTGACCGTCACCGCCCATGTCGAGGCGCACAAGGACTCCTCCTTCCTGCGCAGCATGTCGCTGATGTCGAGCGCGATCTCCGGCAGGCCCGCCGAGGAACTGCAGGAGCGCTACGCCGCGGACTACGCCGAGCTCGGCGGCTCCCACGTGGCGTTCTACGAGCTGTGCGCGCGGCGCGGCGGCGGCTCGGCCCGGCTCGCGGACGTCTCCGCCACCAAGCGCTCCGCCGAGGTCTGGTTCGTCTGA	MLSSALEVDIDEAAVAADLRELAAALDRSGYGEILTCFLPQKAQAHIWAQTAAKIDGPLRTLMELFLLGRAVPQDDLPPRIAAVIPGLVSAGLVKTGQGAVWLPNLILLRPMGQWLWCQRPHPSPTMYFGDDSLALVHRMVTYRGGRALDLCAGPGVQALTAALRSEHVTAVEINPVAAALCRTNIAMNGLSDRMEVRLGSLYDVVRGEVFDDIVSNPPLLPVPEDVQFAFVGDGGRDGFDISWTILDGLPEHLSDRGACRIVGCVLSDGYVPVVMEGLGEWAAKHDFDVLLTVTAHVEAHKDSSFLRSMSLMSSAISGRPAEELQERYAADYAELGGSHVAFYELCARRGGGSARLADVSATKRSAEVWFV	MNKKNIKDSQNFITSKHHINEILRNVHLNTNDNIIEIGSGKGHFSFELAKRCNYVTAIEIDPKLCRITKNKLIEYENFQVINKDILQFKFPKNKSYKIFGNIPYNISTDIIRKIVFESTATESYLIVEYGFAKRLLNTNRSLALFLMTEVDISILSKIPREYFHPKPRVNSSLIVLKRHPSKISLKDRKQYENFVMKWVNKEYIKLFSKNQFYQALKYARIDDLNNISFEQFLSLFNSYKLFNR	152.46	gnl|BL_ORD_ID|1170|hsp_num:0	1275			102	216	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0001155.1|GE2270_8 # 8059 # 9291 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.673	BGC0001155.1|GE2270_8 	8059	9291	+	Loose	1000	30.0314	almE	22.48	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGTCGACGACACTTCGCGGAACAGGCGGCGCAGTCGCCGAGCAGCCCTTGCTGATCTACGTGAACGTTCCGTTCTGCAACTCCAAATGCCACTTCTGCGACTGGGTCACCGAGGTGCCCCTCGCGGATCTGCGGCTCACGCCGGACTCCTCGCCGCGGCAGCGTTACATCGCCGCGCTGGTGCAGCAGATCGAGACCCACGCCCCGGTCCTGACCGGCTTCGGCTACCGGCCGGAGATCATGTACTGGGGTGGCGGCACGGCCAGCATCCTCTCGATCGACGAGATCGAGGCGGTGGCCGGCGCGCTGTCGTCGCGGTTCGACATGAGCGGACTCACCGAGGCCACCATCGAGGGCAGTCCGGAATCCCTGGACCCGGACAAACTGAAGCTGTTCCGCGCGGCCGGGTTCAACCGGATCAGCATCGGCGTCCAGGCGTTCGATGACGCCCGCCTGCGTCGCATCGGCCGCGTCCACTCCGCGGAACAGGCGGTGCGCGCGGTCGAGATGGCCGCCGAGGCGGGGTTCGACAACATCAACATCGACCTGATCGTCGGATTCCCCGGCCAGGAGGTCGACGAGGTGTCCCACATGATCCAGCGGGCCGTCACCCTGCCGGTCAACCACTTCTCCGTGTACCCGTACCGTCCGACGAACGGGACGGTGATGCGCAAACAGGTACGGCGCGGCAACAGCGAGATCGATGTGGACGAGCAGCTGCGGTCCTACGCCTACGCCCGTGACCTGCTCGCCGAACACGGATTCGACGAGTACGCCACCGCCTACTTCGGCGGCCCCCGGTGCGAGTCCGACGAGGTCTACTACAAGCTCACCATGGACTGGATCGGATTCGGCTCCGGTGCGAACTCCCTGATCGGGACGCGGTTCCTGCTGAACGAGCGGGGGGCCCTCCACCGGTTCAGCGCGGCGCCGCAGCGGTTCGACTCCGACATCCCGGCGTCCTCACCCCACCTGACACGCCATTTCCTGGCGCAGGCGCTGACCACCGTGGACGGCATGGACGCGCGGACGTTCCAGCAGCGCACCGGCCGTTCGCTGCGGGCGGCGTGCGAGGAGCCCGCCGTACGGCGGATGCTCGAGCAGATCAACCGGCGTGGCCGGCTGATCATCGACTCGCGCGGCATCCGTCTGCACCGCGACGACATGGCCTCGACCTACATCACGATGAACAGCGTCGACCTGTACGCCGCGACCGAGCAGATCGGCGGATGA	MSTTLRGTGGAVAEQPLLIYVNVPFCNSKCHFCDWVTEVPLADLRLTPDSSPRQRYIAALVQQIETHAPVLTGFGYRPEIMYWGGGTASILSIDEIEAVAGALSSRFDMSGLTEATIEGSPESLDPDKLKLFRAAGFNRISIGVQAFDDARLRRIGRVHSAEQAVRAVEMAAEAGFDNINIDLIVGFPGQEVDEVSHMIQRAVTLPVNHFSVYPYRPTNGTVMRKQVRRGNSEIDVDEQLRSYAYARDLLAEHGFDEYATAYFGGPRCESDEVYYKLTMDWIGFGSGANSLIGTRFLLNERGALHRFSAAPQRFDSDIPASSPHLTRHFLAQALTTVDGMDARTFQQRTGRSLRAACEEPAVRRMLEQINRRGRLIIDSRGIRLHRDDMASTYITMNSVDLYAATEQIGG	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	73.74	gnl|BL_ORD_ID|4935|hsp_num:0	5928			1017	1329	colistin A; colistin B
BGC0001155.1|GE2270_9 # 9417 # 9584 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.619	BGC0001155.1|GE2270_9 	9417	9584	+	Loose	600	22.3274	clbB	35.48	3002815	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target alteration	Cfr 23S ribosomal RNA methyltransferase	ATGAGCGAGATGGAGTTGAACCTTAACGACCTGCCCATGGACGTCTTCGAGATGGCCGACAGCGGCATGGAAGTTGAGTCACTCACCGCGGGACACGGGATGCCCGAGGTCGGTGCCTCGTGCAACTGCGTGTGCGGCTTCTGCTGTTCCTGCAGCCCGTCCGCGTGA	MSEMELNLNDLPMDVFEMADSGMEVESLTAGHGMPEVGASCNCVCGFCCSCSPSA	MKLTSKYETIRRILSECKQPEYRYAQIMDAIFKQNIGEYERMTILPKFLRDELNRILGPNVCSIAPVKELTSKQVSKVLFAIPGDEQVEAVRLTYERGWKSYCISTQCGCGFRCKFCATGTIGLKRNLTADEITDQLLYFRLNGHSLDSISFMGMGEALANPHIFEAMTILTDPYLFGLGHRRITISTIGLLPGIDKLTREFPQVNLTFSLHSPFDDQRSELMPINDRFPVRDVLIALDRHIRETGRKVYIAYILLRGVNDSTAHAEAVAELLRGRGAWEHLYHVNLIPFNSTEVTPDSYRQSDPSRIKAFVRILKSRGISVTVRTQFGSDINAACGQLYRSE	16.03	gnl|BL_ORD_ID|109|hsp_num:0	127			249	342	lincomycin; clindamycin; azidamfenicol; chloramphenicol; thiamphenicol; virginiamycin M1; tiamulin; madumycin II; griseoviridin; dalfopristin
BGC0001155.1|GE2270_10 # 9642 # 12131 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGGGG;rbs_spacer=5bp;gc_cont=0.749	BGC0001155.1|GE2270_10 	9642	12131	+	Loose	1900	28.1054	MexW	29.63	3003031	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; tetracycline antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGTGTGGAGAAAGGCCACGAGATCGTGGTCCGGGTCGCGGGGGTGCCCGCGGCCGTTCTCGGCGGACTGCGCCTGCCGCACTCCGCCGCACTCGTCACGCATCTCATCGCGGAGGACCACCGGCTGACGGCCGAGGCCGCCGTGCTCTCCGACGACCTCTTCGAGCTGATCGGCGACGCCGGACCCGCGCGCGCCGCGCTGGTCGGCCTGCGACGCGCGCTCGCCCCCGGACGTCGCCGCCCCTCCGCGCGACTGATCGAACGGTGCCCCCTGCCGGAGCCCCTGGCCGGCCGGATCACCGCGTGGGCGCGGGCACGGGCGGAATGGGACGGACGGCGCCGCGAACTCGACGACCTGCTGACGAAGGAACGCGCCGACGTGCTCGGCCACGTACGCGCGGCCTGCGCCGACCCCGCGTTCCGGCGGGGCCTGTTCCTGTCCGGCGCCGAACTGTCCGGCACGCTCGACCGCTGGCTGGCCGACCCGGACCGCCCGCCCCGGCCCGGAAAGGTGCTCAGAATCGTCAAATACCTCGCGCGCGCCTCGGCCAAGACCAGCCCGTTCGGCTCCTTCATGGTGAGCGCGCTCACCGGCTGGAGCGACGACGGCATGGGCGCACCGGAGTCCGTCGAGGTGACCGAGCCGTCCGGCGCGTTCCTCGACGCCGTCCGTGACGCGTTGCTCGCCGACCCGCGGCTGGCTGACCGGGTGCCGTTGCGTCCCAACCCGAGCCTGACCGAGGCCGGTGACGCGCTGATGTTCGTGTCCGGGCAGACCGGGGAGCGGATCGCCACGGTCGGGCGGGTGCCCGCGGTCGAGCTCTGCCTGCGGCACGCCGAGTCCCGGCCCACCGCGCCCCGGCTGGCCGGGCTGCTGACCGAGGCAGGCGCCGACCCCGGCGAGGCCGCCCGGTTCGTCTCCCGGATGGTGACGGCGCAGCTGCTGGTGCCGTGCCCGCCGGTCACCGACGACGATCACGACCCGTTCGGCGCCTGGGCCCGCTGGGCGGACCTTCCCGAACTGCGCGAGCTGTCGGCCGCGTTGCGTCCCGTACGGCTCGGACGGCATGGCCGCTCCGGACCCTCCGGACCCTCCGGACCGTCCGGCCCGGACGCCCACCGGCGGCGCCGGGAGAGGACCGCCGCCGCGCTCACCGCCGTGGCGGAACGTCTCGGCATCGACCCGCCCGCCGAACCCGCGCACGAGGTCGAGGTCGGCGTCGGCAGACCGGCGCCGCCGGCGCTGCCCGACGACGTGCTCGCCGATCTGGACGCCGTCCGCCGATGGCTGTCGGTGTTCGACTGGAAGATCCCCGTCCGGGTGAGCGTGGGCGCGTACTGCCGGGAGCACTTCGGCCCCGGTTCCCGGACACCGTTCCTGCTGGTGTGCCGGCAGGCCACGGCGGCCTTGCCCCACCTGTTCGGACCGGCCGCGATGCCGTGGTTCTCCGACCTGACCGGCAGCCCACGCCTGCGCGAGCTGGACCGCCTCCGGGAGCGGGCCCGCGGGCTGGCCCGCTCGGGCGCTCTCGACCGCCGGGAGGTCCTGGACGACACCGCCGACTGGCCCGCGTGGCTGACCTCACCCGCCTCCGTCGGCTTCTACCTGCAGCTCCTTCCCGGAGAGCCCGGGAAGGTCGTGCTGAACGCCGTCCACGCCGGACACGGCCGGGCGTCCGGACGCCTCCACCACCTCCTCGGCCGGGCGGGCGCCGCACCGGAGCGCCCCGCGCGGCCGGGCCCGCCCCTGGCCGAGATCGGCGGGAGGTTCGGTTCGGCGCTCAACACCCGCACGCCGAGCACGCTCCTGGAGATCGACCATCCCGGCGCGGCCTCCGGCCGCGACCCCGGCCATCGGATCCGTCTCGGCGAGCTCATGGTCGTCCACGACCCGGAGACCGATCTGGCCTTCCTGCACAGCGAGCGGTTCGGGCGGATCGAACCGGTGCACCTCGGCATGATGGGCGAGCTGGCGCTGCCCGCCGTGGCCGGGTTCCTCGAACGCGCCTTCGCGCCCACCTACCTGTTCCACCCGAGCGTCCCCCCGCTGATCTCCCTGCGAGACCTCGCCGGAACCGCCGCGACCCGGCGGTTCCCCCGCGTGTCCGTGGGCGGCGTCATCGTGCAGCGTGCCCGCTGGACCGTGCCCGCCGACCGGGTGCCCGCCCGTTCGGGACCGGACGCGGACCATTCGGGATCGGACGGAGACCATCTGCTCGCCCTCGCCCGGTGGCGGCACGCCGAAGGCATCCCCGAACGGTGCTTCGTCCGCGGCTGGAGCCCCGGCGCCGCGTTCGGCAAGGCCCGCAAACCCCTGTACGTCGATTTCGCCTCCTGGCACCTGACGACCCTGTTCGAGCGGGAGGCACGCTCGAACGCCGCCGTCGTCATCGACGAGGCCCTGCCGGACCCCCTGGCCGAAGGCGCTCCGGCCCACGTGACCGAGTACCACATCGAGATCGACACCGGAGGGACGGCTGATGCCTGA	MRVEKGHEIVVRVAGVPAAVLGGLRLPHSAALVTHLIAEDHRLTAEAAVLSDDLFELIGDAGPARAALVGLRRALAPGRRRPSARLIERCPLPEPLAGRITAWARARAEWDGRRRELDDLLTKERADVLGHVRAACADPAFRRGLFLSGAELSGTLDRWLADPDRPPRPGKVLRIVKYLARASAKTSPFGSFMVSALTGWSDDGMGAPESVEVTEPSGAFLDAVRDALLADPRLADRVPLRPNPSLTEAGDALMFVSGQTGERIATVGRVPAVELCLRHAESRPTAPRLAGLLTEAGADPGEAARFVSRMVTAQLLVPCPPVTDDDHDPFGAWARWADLPELRELSAALRPVRLGRHGRSGPSGPSGPSGPDAHRRRRERTAAALTAVAERLGIDPPAEPAHEVEVGVGRPAPPALPDDVLADLDAVRRWLSVFDWKIPVRVSVGAYCREHFGPGSRTPFLLVCRQATAALPHLFGPAAMPWFSDLTGSPRLRELDRLRERARGLARSGALDRREVLDDTADWPAWLTSPASVGFYLQLLPGEPGKVVLNAVHAGHGRASGRLHHLLGRAGAAPERPARPGPPLAEIGGRFGSALNTRTPSTLLEIDHPGAASGRDPGHRIRLGELMVVHDPETDLAFLHSERFGRIEPVHLGMMGELALPAVAGFLERAFAPTYLFHPSVPPLISLRDLAGTAATRRFPRVSVGGVIVQRARWTVPADRVPARSGPDADHSGSDGDHLLALARWRHAEGIPERCFVRGWSPGAAFGKARKPLYVDFASWHLTTLFEREARSNAAVVIDEALPDPLAEGAPAHVTEYHIEIDTGGTADA	MAFTDPFIRRPVLASVVSLLIVLLGMQAFSKLVIREYPQMENALITVTTLYAGANAETIQGYITQPLQQSLASAEGIDYMTSVSRQNYSTISIYARIGANTDRLVTELLAKSNEVKSQLPPDAEDPVLQKEAADASALMYISFYSEQMNNPQITDYLSRVIQPKLATLPGIAEAEILGNQVFAMRLWLDPVKMAAFGVTAGEINQAVQQYNFLAAAGEVKGQLVVTSVNASTDLKSPQAFAAIPVKTDGDRRVLMGDVARVELGAASYDAISSFNGIPSVYIGIKGTPSANPLDVIKEVRAKMPELEEQLPPNLKVSIAYDATRFIQASIDEVVKTLGEAVLIVIVVVFLFLGAFRSVLIPVVTIPLSMIGVLFFMQAMGYSINLLTLLAMVLAIGLVVDDAIVVVENIHRHIEEGKPPFEAALEGAREIAVPVVSMTITLAAVYAPIGFLTGLTGALFKEFAFTLAGAVIISGIVALTLSPMMCSRLLRHEENPSGLAHRLDLIFEGLKQRYQRALHGTLDTRPVVLVFAVLVLALIPVLLMFTKKELAPEEDQGIVFLMTNSPQTANLDYLNRYTAEFEGIFRSFPEYYSAFQINGYNGVQAGIGGMLLKPWDEREKSQMELLHAVQAKLNEIPGVQIFAFNLPSLPGTGEGLPFQFVLNTANDYESLLQVAQRVKQRASESGKFAFLDLDLAFDKPELVVDIDREKAAQMGVSMQDLGVALASLLGEGEINRFTIDGRSYKVIAQVERPYRDNPGWLGSYYVKSRNGQLVALSTLIETHERARPRQLNQFQQLNSAIISGFPIVSMGEAIETVQQIAREEAPRGFAVDYAGASRQYVQEGSALLVTFGLALAIIFLVLAAQFESFRDPLVIMVTVPLSICGALIPLFLGVSSLNIYTQVGLVTLIGLISKHGILIVEFANQLRHEQGLGRREAIEQAAAIRLRPVLMTTAAMVLGVIPLILATGAGAVSRFDIGIVIATGMSVGTLFTLFVLPCIYTLVARPDAPPGVTQAANAH	81.43	gnl|BL_ORD_ID|2018|hsp_num:0	2208			861	1017	erythromycin; acriflavine; tetracycline; chloramphenicol
BGC0001155.1|GE2270_12 # 13013 # 14014 # 1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.740	BGC0001155.1|GE2270_12 	13013	14014	+	Loose	875	26.5646	tet(O/M/O)	37.21	3007120	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	GTGACCTGGCGACGCTTTGACGTGGCCTACCACGACCCGGATCTCGACCGGCTGATCCTGGCGGCGCGGCCGCTGCTCTCGGAGAGCCCCGGCCGCAGCTGGTTCCAGCGGCACTGGGTACGCGGCCCGCATCTGGAGCTCTGGTTCGACCACCCGGAACCCTCGTGGGAGCGGGTGCGGGAGGTGCTGGGCACCCACCTGCGCGCCCACCCGTCCCGCACCAGGATCGACCCGGACCGGCTGCTGCCCCAGCACCGCCGCCTGGCCCTCGCCGAGCAGATCGACGAGCCGCTGCTGCCCTTCTACGACGACAACACGCTGCACCGGGCCGTGCCGCGGTCCCGCGTGCACGTGCTGGGCAGCGCGGCGGCCGAGGATCTGTTCCACGACTTCCACGCCGCCGCCAGCACCGCGGCGTTCGACCAGCTCGACGCGGTGGTGGCGGGGGAGTCCCGGCTGGGGCTGGCGTTCGAGCTGATGATCGCGGCGGCGCACGCCCACGCCGAGGGCGGCATCACCGGCGGGTTCGTGTCGTTCCGCTCACACGCCGAGGCGTTCCTGGCCGGCGCCGCCGGCCTGCGCGAGCGCTGGGAGGCCGAGTACCGCACCCGCGCGGAGGCGTTGCGCGCGCAGGTCGCCGCCGTGGTCACCGGGACCCCGCGCGGCCGGGCCTGGACCGGGTTGCTCGACGGGTTCGCCGGCCGCGGCGACGAGTTGATCGCGTCCGGCGCCCTGACGGTCGAGCCCGCCTCACCGACCGCGGCCGCCGAGCCGGACACCGAGTTCCACCGGGCGTTACGCGCCAACCGGACCTGGCACGACGAGGTGCTGCGGTCACCGTCGTTCCGCCGGTACCGGCTGCTGCTCAACCTGACGTACCTGCAGATGTCCCGGCTGGGGGTGACCGCCGTGCAGCGGTCGCTGCTGTGCCACTTCGCCGCCTCGGCGGTCGAGGAGGAGTACGGGGTGTCCGCCATCGAGATCGCCGTAGGAGGCATGTGA	MTWRRFDVAYHDPDLDRLILAARPLLSESPGRSWFQRHWVRGPHLELWFDHPEPSWERVREVLGTHLRAHPSRTRIDPDRLLPQHRRLALAEQIDEPLLPFYDDNTLHRAVPRSRVHVLGSAAAEDLFHDFHAAASTAAFDQLDAVVAGESRLGLAFELMIAAAHAHAEGGITGGFVSFRSHAEAFLAGAAGLRERWEAEYRTRAEALRAQVAAVVTGTPRGRAWTGLLDGFAGRGDELIASGALTVEPASPTAAAEPDTEFHRALRANRTWHDEVLRSPSFRRYRLLLNLTYLQMSRLGVTAVQRSLLCHFAASAVEEEYGVSAIEIAVGGM	MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAVTSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMKIPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIMGNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYSSTPEGQSELCGQVFKIEYSEERQRLAYVRLYGGILHLRDSVRISEKEKIKITEMYTSINGELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPMLQTTVEPSKPQQREMLLDALLEISDSDPLLQYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIYMERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEGVLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYLHFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTCFTNGQGVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA	52.11	gnl|BL_ORD_ID|4794|hsp_num:0	5790			1038	1161	tetracycline
BGC0001155.1|GE2270_14 # 15372 # 17168 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.741	BGC0001155.1|GE2270_14 	15372	17168	+	Loose	1000	30.0314	MCR-10.2	32.14	3007277	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	ATGGCAGCTCTGAACGTCCTGCTGCGCCCCGACGCGTACTACGCCGAGGTCGACGGCGGCGTCTACTTCATCAGCCACCAGGGCGAGACGTTCATCGCCGGTCCTACGGTGCACCAGTGGCTCGACCGCCTCGCGCCGCTGCTCGACGGCACCCGCACCCTCGACCGGCTCACCGCGGGCCTGCCCGCCGACCGGGCCGCGTTCGTCACCAAACTCGTCGGCGTCCTCGCCGAGCGCGGCCTGGTGCGCATGGTCGGCCCCGGCACGCCGGACACGCTCACCGACGCCGAACGCCACGAGTACCGCGGACTGCTGTCCTATCTCGGCTACTTCAGCGACTCACCCGGCCACGTCCTCGAAAACGTCCTCGACACCCCGACCGTGATCATCGGATCGGACCCGCTGGCGGCCGAGCTGAGCCGCGCGTGCGCCGCCGCGGGACTGCGGAAGGTCGAGATGGCCGACGAGGTGGGCACCGCCCAGGTCGTGGTACACGTGGCCGACCGCGCCGAACCGGAGCGAGCCGTACGGCTGGAGCGGCTCTGCGCCGCGTCCGGAGCCCTGCTGGCGCAGGTCATGCCCGTGGCGGACGGCATCTGGTGGCAGCCCGCGGCCCGGGGCGGTGGCTTGGCGAGCGCCTGGCGCAGGCACCGGGCACTGGCAGGTCCGGTCCCGGCGGCCGGCCCTCCGGACCCGGTGGCGGCCAAGGTGGTGGCGAACCAGGTGGCGCACGACGTGTTCCGGCTCCTGACCGGTCTGCGCGAGGAGACCGCGCCCCGGCTGGTGGTGTTCGACCCGCGGACCATGGCGAGCACCACGCATCCGATCATTCCGCACCCGCTCGACCTGCCCGCCGAACCGCTGGACGAGGCCGCGTTCCTCGACCGGATCACCTCGCTGCGCACCGCCCCCGCGGTGAGCGAGGAGGAGTTCTCCCGGCGGGCCAAGGGGCTGATGGACGGGAGAACCGGACTGTTCGCCGAGATCGACGAGGGCGATCTCGCGCAGTTGCCGCTGCACGTCACGGCGACCACGGTGTCAGACCCGTGCGGGAGACTGGGCGACGCGCCCAGGCCGGTGGTCACCGGCGCCGGTTTCACCTTCGAGGAGGCCCGCTACCGGGCGGCGCTCGCGGCCCTGGCGCGCGCCGGCACGCTGACGCTCGACGAACGGCGGCTGATCGACGGCCACGTGCACGCCTACGACCTGGTGGACCACACGGCACGCCTGGTGCCGGCGGAGACCGTCTTCGGCGCGTCGCGTGGTGCCGCGGCGGCGTACTCATGGGACGAGGCGGTCGCCGCGGGCCTGACCGCCCACGCGGCCGCGCTCACCCTCGACGGGATCGCGCACGTCACCGAGCCGTTCGGGCGGGTGGACCTGACGGAGGCGCCGGAGTACTGCCTGGCGATGATCCGCGCGCTCGGCGAGAAGCCGGCCGTGTACGACGTCACCGGACCGCTGGGTGCGCCCACGGTGGTCGGGACGCTCTCCGGCGGGGCCACCGCGTGCGGTGCGGCCCTGACGATCGAGGCCGCCGTGGCCGCATGCCTCCGCGACCTGCTGCTGGTCCGCCAGGCCGAGATCAACGATCAGCCGGTCTACGCCCCGGCGCCGTGCGCGCCCCCGTCCCCGGCGCTTCAGGGGGATCACCTGGCGCCCCGGCGGCCGGGCACCGATGTGCCCACGCTCGTGGCGAGACTGGCCGAGCAGGGCCGCCGTCCGCTGGCGGTGCCGCTCGACCACGACCCGGCCGTGCACGCGGCCCTGCCCTTCGTCGTCCAGGTGGTGTGCTGA	MAALNVLLRPDAYYAEVDGGVYFISHQGETFIAGPTVHQWLDRLAPLLDGTRTLDRLTAGLPADRAAFVTKLVGVLAERGLVRMVGPGTPDTLTDAERHEYRGLLSYLGYFSDSPGHVLENVLDTPTVIIGSDPLAAELSRACAAAGLRKVEMADEVGTAQVVVHVADRAEPERAVRLERLCAASGALLAQVMPVADGIWWQPAARGGGLASAWRRHRALAGPVPAAGPPDPVAAKVVANQVAHDVFRLLTGLREETAPRLVVFDPRTMASTTHPIIPHPLDLPAEPLDEAAFLDRITSLRTAPAVSEEEFSRRAKGLMDGRTGLFAEIDEGDLAQLPLHVTATTVSDPCGRLGDAPRPVVTGAGFTFEEARYRAALAALARAGTLTLDERRLIDGHVHAYDLVDHTARLVPAETVFGASRGAAAAYSWDEAVAAGLTAHAAALTLDGIAHVTEPFGRVDLTEAPEYCLAMIRALGEKPAVYDVTGPLGAPTVVGTLSGGATACGAALTIEAAVAACLRDLLLVRQAEINDQPVYAPAPCAPPSPALQGDHLAPRRPGTDVPTLVARLAEQGRRPLAVPLDHDPAVHAALPFVVQVVC	MPVLFRMRVIPLVLLLALVFAFLLNWPVLLHFYDILSRLEHVRAGFVISIPFVLVAALNFVFMPFSVRYLLKPFFALLLVTGSVVSYATLKYKVMFDQSMIENILETNPQEAHSYLNGSLVLWLVFMGILPAILLFLIKIEYTDKWYKGVAHRLLSMLASLILIAGVAALYYQDYASVGRNNPTLNKEIIPANYAYSTFHYVKDTYFTTKMPFRTLGDDARRVTRNGKPTLMFLVIGETARSQNFSMNGYPRDTNAFTSKIDGVISFRNMRSCGTATAVSVPCMFSDMNRTDYDGKKAAGSENVLDIVQKTGVSLLWKENDGGCKGVCSRIPTVEINPGISKKLCDGKTCYDDVMLENLDTEIGKMAGDKLIAFHMIGSHGPTYYQRYPAEHRHFMPECARSDIENCTQEQLVNTYDNTIRHTDYVLAQMIEKLKQYSEQYNTVLLYVSDHGESLGESGLYLHGTPYKLAPDQQTHIPMQLWMSPDFIAAKNINAACLQHNAVNRTYSHDNLFASVLGLWDITTGAYLPESDLFRECRG	110.95	gnl|BL_ORD_ID|4705|hsp_num:0	5882			720	885	colistin A; colistin B
BGC0001155.1|GE2270_15 # 17168 # 18904 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.721	BGC0001155.1|GE2270_15 	17168	18904	+	Loose	500	28.8758	cphA7	33.93	3003103	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	CphA beta-lactamase	ATGATCCGTGTGCCGGACAGCGGCGAACTGACCGTCGCGCTGGAGAAAGGCCCGAGGCTCCCGGTCCGGACGGAACTGGGCCGGATCACCGTCGGCCCGCTGGAACGGCCGGGCGTGCCGGGGTGCCGGGAATGCGTGCGCGTCCGGGAGAGGCGCGTCCAGCCCGACGCCCGCAAGGCCGAAGCCGTGCGCGCCCTGCACACCCCGGCAGCGAGTCAGTGGCTCACCCCGCTCGCCACCGACCTGGTCCACACCCTGGTCGCGAGCGAGGCCGCCGCGCTGGCGGCCGACGCGGAGCCCCGGACCGTGAACGCCGTGCTGGAGATCGACCTGATGACCCTGGAGATCACCCGGCACCGGTTCCTGCCGGATCCGCTGTGCGCGCACTGCGGGGACCTGCCGCCGGACGCCCCGGCGGAGCTCACCCTCCGGTCCCGGCGCAAGCTCGGCGGCAGCCCGCGGACCAGGGAGATCGAGCTCGACGCGCTCCTGGAGACCTACGTGGACGGCCGGACCGGCATGATCCGCCCGCTGAAGACCGGCGTGCAGGGCGGTCTCACGGTGGCGAGCGCGATGCTGCCGATCCGCGCGGGCAACGGCCTCGAACCGGGCGTCGGCCGCACCCGGAACTACCGCGCCAGCAAGCTCACCGCCGTGCTGGAGGCGCTGGAACGCTACGGCGGCGTGAGTCCCGGGGGCCGCCGCACGGTGATCAGGTCCGCCTACCGCGACATCGCCGGTGACGCCGTCCACCCCGATGGGTTCGGCACGCATCCGGAGGAGAACTACGACCGTCCCGACTTCGAGTTCCGCCGGTTCACCGAGGACACGGTGTGCCGATGGGTGTGGGGCTACTCGTTCGCGCAGTCGCGGCCCGTCCTGGTGCCGGAGAATCAGGTCTACTACTACGCCCGGCACATGCCCGACGGCGAGAAGCCGTTCGTCTTCGAGGTCTCCAACGGATGCGCGCTCGGCTCGTGTCTGGAGGAGGCGATCCTCCACGGCCTGCTGGAGGTCGTCGAACGCGACGCGTTCCTGCTCACCTGGCATGCCCGGCGGCAGGTCCCGGTGCTGGACCCCGCGCTGGCGGCCGACCCGGTGCTGCCGATGCAGGTCGCCGCGATCACTGCTGAGACGGGACATCGGGTGCTGTGCTTCGACACCACGGCGGAACACGGCATCCCGAGCGTGTGGGTCATGGCGGTGGACGCCGAACGCCGCCCGGACCAACCCGCCACCGCCCACGCCGCCGGCTCGGCGCTCACGCTGGAGAAGGCCACGATGAACGCCCTCAGCGAACTGGGACCGCTGCTGGCGGATGTGATCCGCCGCTACCCGCAGCAGCGGGAGCGGGCGCAGGCCATGGTCCGCGACCCGGAGGAGGTCGTCACCATGCACGACCACTCGATCCTCTACGCCGCGCCGGAGGCGGCGGACCGGCTGGACTTCCTCATCGGCCGCGCCGACGGCCCGAAGGTGGGGTTCGGCACGGACCGGTTCACCGGTGACGACCTCACCGCGGACCTGCGGGCCATGATCGATGCGGTGCTGGCGGCCGGAATGGACGTGGTGGTGGTCGACCAGACCACCCCCGAGCACCTGGCGGGCGGATTCCGCTGCGTGAAGGTGCTGGTGCCCGGCGCGTTGCCGATGACGTTCGGCCATCGGCACCGGCGGCTGGGAAACCTGCCGCGGCTGGAGACCGTACGGACCACCGATCCGCACCCGTTCCCGTGA	MIRVPDSGELTVALEKGPRLPVRTELGRITVGPLERPGVPGCRECVRVRERRVQPDARKAEAVRALHTPAASQWLTPLATDLVHTLVASEAAALAADAEPRTVNAVLEIDLMTLEITRHRFLPDPLCAHCGDLPPDAPAELTLRSRRKLGGSPRTREIELDALLETYVDGRTGMIRPLKTGVQGGLTVASAMLPIRAGNGLEPGVGRTRNYRASKLTAVLEALERYGGVSPGGRRTVIRSAYRDIAGDAVHPDGFGTHPEENYDRPDFEFRRFTEDTVCRWVWGYSFAQSRPVLVPENQVYYYARHMPDGEKPFVFEVSNGCALGSCLEEAILHGLLEVVERDAFLLTWHARRQVPVLDPALAADPVLPMQVAAITAETGHRVLCFDTTAEHGIPSVWVMAVDAERRPDQPATAHAAGSALTLEKATMNALSELGPLLADVIRRYPQQRERAQAMVRDPEEVVTMHDHSILYAAPEAADRLDFLIGRADGPKVGFGTDRFTGDDLTADLRAMIDAVLAAGMDVVVVDQTTPEHLAGGFRCVKVLVPGALPMTFGHRHRRLGNLPRLETVRTTDPHPFP	MMKGWMKCGLAGAVVLMASFWGGSVRAAGISLKQVSGPVYVVEDNYYVKENSMVYFGAKGVTAVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQTRDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFKLQDGKVRAFYAGPAHTPDGIFVYFPDEQVLYGNCILKEKLGNLSFANVKEYPQTIERLKAMKLPIKTVIGGHDSPLHGPELIDHYEALIKAAAHS	227.56	gnl|BL_ORD_ID|122|hsp_num:0	143			591	753	
BGC0001155.1|GE2270_16 # 18921 # 19289 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.661	BGC0001155.1|GE2270_16 	18921	19289	+	Loose	200	25.409	FosA4	38.46	3003210	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic inactivation	fosfomycin thiol transferase	ATGTACGTGGTGATCGTCGCGTTCGACCTGAAGGACTCCGCCATCGACTTCGCCGAACTGCGCGCCTGGGTGCACGACCGGGCGGCGGACGATTACTCCAGGCTGCCGGGGATGCGCTTCAAGGCGTGGTTCTCCGACGAGAGGAAACGGCTGTGGGGCGCGGTCTACCTGGTGGAGTCGATGTCGTCGTTCGACCGGGACAAGATCCCGCTGCTGCCCGACGGAGCCACCGGACCGGTCGGCACCCGGCCGACCTCGATCATGTTCCTGGAACTTGAGGCGTTCGTCGCCGGACCCGACGGTATCGCCGGGATCGAAGCGCTCACCCGGCAGGGGCTGAGCATGGTGGGAGGCAGTCATGACCACTGA	MYVVIVAFDLKDSAIDFAELRAWVHDRAADDYSRLPGMRFKAWFSDERKRLWGAVYLVESMSSFDRDKIPLLPDGATGPVGTRPTSIMFLELEAFVAGPDGIAGIEALTRQGLSMVGGSHDH	MLQGLNHLTLAVSDLASSLAFYQRLPGMRLHARWDSGAYLSCGALWLCLSLDAQRRKTPAQESDYTHYAFSVAEEHFAEVVAQLAHAGAEVWKDNRSEGASYYFLDPDGHKLELHVGHLAQRLAACRERPYKGMVFFD	88.41	gnl|BL_ORD_ID|1828|hsp_num:0	1979			63	177	fosfomycin
BGC0001155.1|GE2270_18 # 20506 # 21522 # 1 # ID=1_18;partial=00;start_type=GTG;rbs_motif=GGG;rbs_spacer=8bp;gc_cont=0.739	BGC0001155.1|GE2270_18 	20506	21522	+	Loose	800	25.7942	Staphylococcus aureus LmrS	32.73	3004572	protein homolog model	n/a	n/a	macrolide antibiotic; aminoglycoside antibiotic; oxazolidinone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGGAGGCGATGCGCACGGTGCTCGCCGCCGCGGACCTGGCGACGCCCATGGCCGTCCGGGTCGCGGCGACGCTGAGGCTGGCCGACCGCATCGCGGCCGGAACGGATTCCGCGGCCGCACTCGCCGCGGCCGCGGGGGCCGATGAGGCGGCACTGACGCGGTTGCTGCGCTACCTGGTCGCGCGGGACATCTTCCGCGAACCGTCACCGGGGCGTTTCGCCCTGAGCCCGGCCGCGGAGCTGCTGCGCGGCGACCGCCCGGAGCGGTTGCGCGACTGGCTGGACCTCACCGGCCCGATCGGCCGCGCGGACCTGGCGTTCGGGTCGCTGCTGGACGTCGTGCTCACCGGCAGGCCCGGATACCCGATGATCCATGGACGGGGCTTCTGGGACGACCTCGCCGGCCGGCCCGAGCTCGCCGCCGCGTACGACGCCCTGATGGGCGGCAAGCGCGACTGGGCGGCGACCACCCTCGCCGCGCTCGACTGGAGCCGTTCCCGGCATGTGGTGGACGTCGGCGGCGGCAACGGCACCCTGCTGTCGTGTGTCCTGGCCGCGCATCGGCATCTGCGCGGCACTGTCGTGGACCGGCCCTCGTCCGCCGAGGCCGCCGGGGCGGTGCTGGCGTCGGCGGGCGTTGCGGACCGCTGCGAGTTCCGGGCGGGGGACTTCTTCGAACCGTTGCCGGTGAAGGGTGCCGACACCTATCTGCTGAGTTCGATCGTGCACGACTGGGACGACTCCTCGGCGGTCGCGATCCTGCGCCGCTGCGCGGAGGCCGCCGGGCCGGGCGGCCGGATACTGCTGTGTGAGCTGATGGCCGGAGGCGGGCGGGACCAGCGGGCGGTGACACAGATGGACCTGTGCATGCTCGTGTACTTCGGCGGGCGGGAACGCACCGGGGACGAGTTCGCCGCGCTGGCCGAGCGTGCCGGACTGGAACTGCGGACGGTGACGCCGCTGCCGCCGCATGACTGGGGCAACTCGCTCATCGAGTGCGTGGTCACCGGGGGCTGA	MEAMRTVLAAADLATPMAVRVAATLRLADRIAAGTDSAAALAAAAGADEAALTRLLRYLVARDIFREPSPGRFALSPAAELLRGDRPERLRDWLDLTGPIGRADLAFGSLLDVVLTGRPGYPMIHGRGFWDDLAGRPELAAAYDALMGGKRDWAATTLAALDWSRSRHVVDVGGGNGTLLSCVLAAHRHLRGTVVDRPSSAEAAGAVLASAGVADRCEFRAGDFFEPLPVKGADTYLLSSIVHDWDDSSAVAILRRCAEAAGPGGRILLCELMAGGGRDQRAVTQMDLCMLVYFGGRERTGDEFAALAERAGLELRTVTPLPPHDWGNSLIECVVTGG	MAKVELTTRRRNFIVAVMLISAFVAILNQTLLNTALPSIMRELNINESTSQWLVTGFMLVNGVMIPLTAYLMDRIKTRPLYLAAMGTFLLGSIVAALAPNFGVLMLARVIQAMGAGVLMPLMQFTLFTLFSKEHRGFAMGLAGLVIQFAPAIGPTVTGLIIDQASWRVPFIIIVGIAILAFVFGLVSISSYNEVKYTKLDKRSVMYSTIGFGLMLYAFSSAGDLGFTSPIVIGALILSMVIIYLFIRRQFNITNALLNLRVFKNRTFALCTISSMIIMMSMVGPALLIPLYVQNSLSLSALLSGLVIMPGAIINGIMSVFTGKFYDKYGPRPLIYTGFTILTITTIMLCFLHTDTSYTYLIVVYAIRMFSVSLLMMPINTTGINSLRNEEISHGTAIMNFGRVMAGSLGTALMVTLMSFGAKIFLSTSPSHLTATEIKQQSIAIGVDISFAFVAVLVMAAYVIALFIREPKEIESNRRKF	70.42	gnl|BL_ORD_ID|2869|hsp_num:0	3276			201	348	erythromycin; streptomycin; kanamycin A; linezolid; trimethoprim; chloramphenicol; florfenicol
BGC0001155.1|GE2270_19 # 21829 # 21963 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.556	BGC0001155.1|GE2270_19 	21829	21963	+	Loose	525	20.7866	LRA-1	61.9	3002482	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	class A LRA beta-lactamase	ATGGTCTCTTCCTGGAGTCTACTCAGGGCGAGTGTGCTTCCATTAAGCGCGACACGCCCGACTGCGTGGGTCGGCGATGGAGAGATAACAGCAGGTCATGACACCGGCAGTACCTGCAAAAAGCAAGAAACCTGA	MVSSWSLLRASVLPLSATRPTAWVGDGEITAGHDTGSTCKKQET	MNPPIHRRTLLLAASVLPLASACTAWSAKGPQQDASAQLAALEAASGSRLGVVGFNTATGARVQHRAEERFPFCSTFKLMLAAAVLERSAKEGDLLARRVNYSKGDLVSYSPITEKNVATGMTVAELCAATVQYSDNGAANLLMKILGGPSAVTAFARASGDEVFRLDRWETELNTAIPGDLRDTTTPAAMAASVQRLVLGNALGAAQREQLKTWLLGNTTSTQRFLAGVPAGWKVGDKTGSGSYGTTNDVGVLWPPAGAPLVLAVYLTFPQKEAKGRSDVVASATRIAVSALAS	14.92	gnl|BL_ORD_ID|1464|hsp_num:0	1601			30	90	
BGC0001155.1|GE2270_21 # 22404 # 22874 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.673	BGC0001155.1|GE2270_21 	22404	22874	+	Loose	650	24.6386	EreA	30.23	3000361	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide esterase	ATGCCTCGCAAGGGTTCTCCTGGCCGTCGTCAGCTCACGCCCGACCCTGTCCACAACTCGCCGCTGGTCACCGCGCTCATCAACAAGGTGCTCCTGGACGGCAAGCGCTCGATCGCGCAGTCGATCGTCTACGGTGCCCTTGAGGGATGCCGCGACAAGACCGGCAACGACCCGGTCGTCACGCTGAAGCGCGCTCTGGACAACGTCAAGCCCACCCTTGAGGTCCGCAGCCGCCGCGTCGGCGGTGCGACCTACCAGGTCCCGGTCGAGGTGCGCGCCGCGCGCAGCACCACCCTGGCCCTGCGCTGGCTGGTGCAGTACTCCCGCGCCCGCCGCGAGAAGACCATGACCGAGCGCCTGATGAACGAACTGCTCGACGCCAGCAACGGCCTCGGCGCTTCGGTCAAGAAGCGCGAGGACACCCACAAGATGGCCGAGTCCAACAAGGCCTTCGCCCACTACCGCTGGTAA	MPRKGSPGRRQLTPDPVHNSPLVTALINKVLLDGKRSIAQSIVYGALEGCRDKTGNDPVVTLKRALDNVKPTLEVRSRRVGGATYQVPVEVRAARSTTLALRWLVQYSRARREKTMTERLMNELLDASNGLGASVKKREDTHKMAESNKAFAHYRW	MTWRTTRTLLQPQKLDFNEFEILTSVIEGARIVGIGEGAHFVAEFSLARASLIRYLVERHEFNAIGLECGAIQASRLSEWLNSTAGAHELERFSDTLTFSVYGSVLIWLKSYLRESGRKLQLVGIDLPNTLNPRDDLAQLAEIIQLIDHLMKPHVDMLTHLLASIDGQSAVISSAKWGELETARQEKAISGVTRLKLRLASLAPVLKKHVNSDLFRKASDRIESIEYTLETLRIMKTFFDGTSLEGDTSVRDSYMAGVVDGMVRANPDVKIILLAHNNHLQKTPVSFSGELTAVPMGQHLAERVNYRAIAFTHLGPTVPEMHFPSPKSPLGFSVVTTPADAIREDSMEQYVIDACGTENSCLTLTDAPMEAKRMRSQSASVETKLSEAFDAIVCVTSAGKDSLVAL	38.42	gnl|BL_ORD_ID|917|hsp_num:0	991			492	621	erythromycin; roxithromycin; clarithromycin
BGC0001155.1|GE2270_22 # 22911 # 25004 # 1 # ID=1_22;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.656	BGC0001155.1|GE2270_22 	22911	25004	+	Loose	1350	809.29	Staphylococcus aureus fusA with mutation conferring resistance to fusidic acid	58.25	3003735	protein variant model	V90I	Q125R:2137	fusidane antibiotic	antibiotic target alteration	antibiotic resistant fusA	GTGGCCACCACGCTTGACCTGGCCAAGGTCCGAAACATCGGCATCATGGCCCACATCGACGCGGGCAAGACCACGACGACCGAGCGCATCCTGTTCTACACCGGTATCACTTACAAGATCGGTGAGGTCCACGAGGGCGCAGCCACGATGGACTGGATGGAGCAGGAGCAGGAGCGTGGTATCACCATCACCTCCGCTGCCACCACCTGTGAATGGCTCGGCCACACGATCAACATCATCGACACGCCGGGTCACGTCGACTTCACCATCGAGGTCGAGCGTTCGCTGCGCGTCCTCGACGGCGCCGTCGCCGTGTTCGACGGTGTGGCGGGTGTCGAGCCGCAGTCCGAGACGGTGTGGCGTCAGGCTGACCGCTACAACGTGCCCCGCATCTGTTTCGTCAACAAGATGGACCGGGTCGGCGCGGAGTTCCACCGCTGCGTCGACATGATGGTCAGCCGGCTGAACGCGACTCCCGCGGTCATCCAGCTTCCCTGGGGCGTCGAGGCCGGCTTCAAGGGCGTCATCGACCTGGTGAAGATGAAGGGCCTGCTCTGGAGCGCCGAGGCGGCCAAGGGCGAGATGTACGAGACCGTGGACATCCCGGCGGACCACGTCGAGGCTGCCCGCGAGTGGCGTGACAAGCTCGTCGAGACCGTCGCCGAGAACGACGACGAGCTGATGGAGCTCTTCCTGGAGGGTGTCGAGCCCACCGAGGAGCAGCTGGTCGCGGCCATCCGCCGCGCCACGCTGTCCGGTTCCATCAACCCGGTCCTGACCGGCACCGCGTTCAAGAACAAGGGCGTGCAGCCCCTGCTCGACGCGATCGTCGCCTACCTCCCCGCGCCGACCGACATCCCGGCCTTCAAGGGCCACGCGGTCAACAACGAGGAAGAGGTCATCGAGCGTCACGCGGATGTGAAGGAGCCCTTCTCCGCGCTGGCCTTCAAGATCATGAGTGACCCGCACCTGGGCCGTCTCACCTACATCCGCATCTACTCGGGCACGCTCGAGTCCGGTTCCGGGGTCATCAACTCCGTGAAGGGCAAGAAGGAGCGGATCGGCAAGATCTACCAGATGCACGCGAACAAGCGCGAGGAGCGCCCGTCCGCGCACGCCGGTCAGATCGTCGCCGTCATGGGGCTGAAGGACACCACCACCGGTGACACCCTGTGCGACCCGGCCCACCCGGTCGTCCTGGAGTCGATGACGTTCCCGGCCCCGGTCATCAACGTCGCGATCGAGCCCAAGACCAAGGGCGACCAGGAGAAGCTCAGCACCGCCATCCAGCGGCTGGCCGAGGAGGACCCGTCCTTCCAGGTCCGCCGGGATGAGGAGACCGGTCAGACGGTCATCTGGGGTATGGGCGAGCTCCACCTGGAGATCCTGGTCGACCGGATGCGCCGCGAGTTCAAGGTCGAGGCCAACGTCGGCCGGCCCCAGGTGGCGTACCGGGAGACCATCCGCCGCAAGGTGGAGAAGGTCGACTACACGCACAAGAAGCAGACCGGTGGCTCCGGCCAGTTCGCCAAGGTCATCATTGACATTGAGCCGCTGGGCGAGGGCAACGACGGGTACGAGTTCGAGAACAAGGTCACCGGTGGCCGCATTCCGCGGGAGTACATCCCGTCGGTCGACGCGGGTGCCCAGGAGGCCGCCGAGTTCGGTGTTCTCGCCGGCTACCCGATGGTCGGGGTCAAGGTCACCCTGCAGGACGGCGCCTACCACGAGGTCGACTCGTCCGAAATGGCCTTCAAGATCGCTGGCTCGATGGCCTTCAAGGAGGCCGCGCGCAAGGCGGACGCCGTAATCCTGGAGCCGGTGATGGCCGTCGAGGTCACCACGCCCGAGGACTACATGGGTGACGTCATCGGTGACCTCAACGGTCGCCGCGGACAGATCCGTGCGATGGACGAGCGTGCCGGCGCCCGCGTCGTCCAGGCGCTCGTACCGCTCTCTGAGATGTTCGGTTACGTGGGTGACCTGCGTAGCAAGACGCAGGGACGGGCGAGCTTCAGCATGCAGTTCGACTCCTACGCGGAAGTGCCTCAGCACATCGCCAAGGAGATCGTCGCGAAGGTGCGGGGCGAGTAA	MATTLDLAKVRNIGIMAHIDAGKTTTTERILFYTGITYKIGEVHEGAATMDWMEQEQERGITITSAATTCEWLGHTINIIDTPGHVDFTIEVERSLRVLDGAVAVFDGVAGVEPQSETVWRQADRYNVPRICFVNKMDRVGAEFHRCVDMMVSRLNATPAVIQLPWGVEAGFKGVIDLVKMKGLLWSAEAAKGEMYETVDIPADHVEAAREWRDKLVETVAENDDELMELFLEGVEPTEEQLVAAIRRATLSGSINPVLTGTAFKNKGVQPLLDAIVAYLPAPTDIPAFKGHAVNNEEEVIERHADVKEPFSALAFKIMSDPHLGRLTYIRIYSGTLESGSGVINSVKGKKERIGKIYQMHANKREERPSAHAGQIVAVMGLKDTTTGDTLCDPAHPVVLESMTFPAPVINVAIEPKTKGDQEKLSTAIQRLAEEDPSFQVRRDEETGQTVIWGMGELHLEILVDRMRREFKVEANVGRPQVAYRETIRRKVEKVDYTHKKQTGGSGQFAKVIIDIEPLGEGNDGYEFENKVTGGRIPREYIPSVDAGAQEAAEFGVLAGYPMVGVKVTLQDGAYHEVDSSEMAFKIAGSMAFKEAARKADAVILEPVMAVEVTTPEDYMGDVIGDLNGRRGQIRAMDERAGARVVQALVPLSEMFGYVGDLRSKTQGRASFSMQFDSYAEVPQHIAKEIVAKVRGE	MAREFSLEKTRNIGIMAHIDAGKTTTTERILYYTGRIHKIGETHEGASQMDWMEQEQDRGITITSAATTAAWEGHRVNIIDTPGHVDFTVEVERSLRVLDGAVTVLDAQSGVEPQTETVWRQATTYGVPRIVFVNKMDKLGANFEYSVSTLHDRLQANAAPIQLPIGAEDEFEAIIDLVEMKCFKYTNDLGTEIEEIEIPEDHLDRAEEARASLIEAVAETSDELMEKYLGDEEISVSELKEAIRQATTNVEFYPVLCGTAFKNKGVQLMLDAVIDYLPSPLDVKPIIGHRASNPEEEVIAKADDSAEFAALAFKVMTDPYVGKLTFFRVYSGTMTSGSYVKNSTKGKRERVGRLLQMHANSRQEIDTVYSGDIAAAVGLKDTGTGDTLCGEKNDIILESMEFPEPVIHLSVEPKSKADQDKMTQALVKLQEEDPTFHAHTDEETGQVIIGGMGELHLDILVDRMKKEFNVECNVGAPMVSYRETFKSSAQVQGKFSRQSGGRGQYGDVHIEFTPNETGAGFEFENAIVGGVVPREYIPSVEAGLKDAMENGVLAGYPLIDVKAKLYDGSYHDVDSSEMAFKIAASLALKEAAKKCDPVILEPMMKVTIEMPEEYMGDIMGDVTSRRGRVDGMEPRGNAQVVNAYVPLSEMFGYATSLRSNTQGRGTYTMYFDHYAEVPKSIAEDIIKKNKGE	100.58	gnl|BL_ORD_ID|4695|hsp_num:0	2254			0	2079	fusidic acid
BGC0001155.1|GE2270_23 # 25094 # 26287 # 1 # ID=1_23;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.642	BGC0001155.1|GE2270_23 	25094	26287	+	Strict	700	809.675	Planobispora rosea EF-Tu mutants conferring resistance to inhibitor GE2270A	99.75	3003361	protein variant model	G261S, V278A, G279A, V295C	n/a	elfamycin antibiotic	antibiotic target alteration	elfamycin resistant EF-Tu	GTGGCCAAGGCCAAGTTCGAGCGGACCAAGCCGCACATGAACATCGGCACCATTGGGCATATCGACCACGGCAAGACCACTCTGACCGCGGCGATCACCAAGGTGCTCCACGACCGGTACCCCGAGCTGAACAAGGCGACCCCGTTCGACAAGATCGACAAGGCGCCCGAGGAGAAGGCTCGTGGCATCACGATCTCCATCGCGCACGTCGAGTACCAGACCGAGAAGCGCCACTACGCCCACGTGGACTGCCCCGGTCACGCCGACTACGTGAAGAACATGATCACCGGTGCTGCTCAGATGGACGGCGCCATCCTCGTGGTCGCCGCCACCGACGGCCCGATGCCGCAGACGAAGGAGCACGTCCTCCTGGCCCGTCAGGTCGGCGTCCCCTACATCGTCGTGGCCCTGAACAAGGCCGACATGGTGGACGACGAGGAGATCCTGGAGCTCGTCGAGCTCGAGGTCCGCGAGCTGCTCTCGGCTCAGGAGTTCCCCGGCGACGACCTGCCGGTCGTGCGCGTCTCCGCTCTCAAGGCCCTCGAGGGCGACGAGAAGTGGGCCGACAGCATCATCGAGCTGATGAACGCTGTGGACGAGAACATCCCCGAGCCGCCGCGTGACACCGACAAGCCGTTCCTCATGCCGATCGAGGACGTCTTCTCGATCACCGGTCGTGGAACCGTCGTCACCGGCCGTATCGAGCGCGGTGTCGTCAAGGTCAACGAGCAGGTCGACATCATCGGCATCAAGAGCGAGAAGACCACGACCACCGTCACCAGCATCGAGATGTTCAACAAGATGCTGGACGAGGGCCACGCGGGTGACAACGCGGCCCTGCTGCTCCGCGGCATCAAGCGTGAGCAGGTCGAGCGCGGCCAGTGCATCATCAAGCCGGGCACGACCACCCCGCACACCGAGTTCGAGGCTCAGGTCTACATCCTGTCCAAGGACGAGGGCGGCCGCCACACGCCGTTCTTCAACAACTACCGTCCGCAGTTCTACTTCCGTACGACTGACGTGACCGGTGTCGTGAACCTGCCCGAGGGCACCGAGATGGTCATGCCCGGTGACAACACCGAGATGACCGTCCAGCTCATCCAGCCGATCGCGATGGAGGAAGGCCTCAAGTTCGCGATCCGTGAGGGTGGCCGGACCGTCGGCGCCGGCCGCGTCACCAAGATCCTCAAGTAG	MAKAKFERTKPHMNIGTIGHIDHGKTTLTAAITKVLHDRYPELNKATPFDKIDKAPEEKARGITISIAHVEYQTEKRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTKEHVLLARQVGVPYIVVALNKADMVDDEEILELVELEVRELLSAQEFPGDDLPVVRVSALKALEGDEKWADSIIELMNAVDENIPEPPRDTDKPFLMPIEDVFSITGRGTVVTGRIERGVVKVNEQVDIIGIKSEKTTTTVTSIEMFNKMLDEGHAGDNAALLLRGIKREQVERGQCIIKPGTTTPHTEFEAQVYILSKDEGGRHTPFFNNYRPQFYFRTTDVTGVVNLPEGTEMVMPGDNTEMTVQLIQPIAMEEGLKFAIREGGRTVGAGRVTKILK	MAKAKFERTKPHMNIGTIGHIDHGKTTLTAAITKVLHDRYPELNKATPFDKIDKAPEEKARGITISIAHVEYQTEKRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATAGPMPQTKEHVLLARQVGVPYIVVALNKADMVDDEEILELVELEVRELLSAQEFPGDDLPVVRVSALKALEGDEKWADSIIELMNAVDENIPEPPRDTDKPFLMPIEDVFSITGRGTVVTGRIERGVVKVNEQVDIIGIKSEKTTTTVTSIEMFNKMLDEGHAGDNAALLLRGIKREQVERGQCIIKPGTTTPHTEFEAQVYILSKDEGGRHTPFFNNYRPQFYFRTTDVTGVVNLPEGTEMVMPGDNTEMTVQLIQPIAMEEGLKFAIREGGRTVGAGRVTKILK	100.00	gnl|BL_ORD_ID|2040|hsp_num:0	2257			0	1191	GE2270A
